The InVivoMAb Anti-SARS-CoV-2 RBD (JN.1) Neutralizing (Iv0222) Antibody from Cell Sciences is a Human Monoclonal antibody to S. This antibody recognizes 2019-nCoV, Corona Virus, Coronavirus, COVID-19, SARS-CoV-2, and Virus antigen. The InVivoMAb Anti-SARS-CoV-2 RBD (JN.1) Neutralizing (Iv0222) Antibody has been validated for the following applications: EIA, Immunoassay, In Vivo, Block/Neutralize/Inhibit, and ELISA.